What is Stelara (Crohn's Disease) Stelara?
Stelara is a medication that is used to treat Crohn's Disease. It contains the active ingredient ustekinumab, which is a biologic medicine. Stelara is administered either through intravenous infusion or subcutaneous injection, depending on the dose and frequency of treatment.
Stelara was approved by the FDA in 2016 for the treatment of moderate to severe Crohn's Disease in adult patients. It is also approved for the treatment of psoriasis and psoriatic arthritis in adult patients.
Clinical studies have shown that treatment with Stelara can result in significant benefits for patients with Crohn's Disease. It has been shown to induce remission in patients who have not responded to other treatments, and also to maintain remission over time. However, like all medications, Stelara may not be suitable for everyone and can cause side effects.
Stelara is available with cost support options for patients to make it more affordable. Janssen CarePath Savings Program is one of the programs that may make paying for Stelara more affordable.
If you are considering Stelara for the treatment of Crohn's Disease , it is important to talk with your doctor to discuss the benefits and risks of this medication, as well as any other treatment options that may be appropriate for you.
Frequently Asked Questions about stelara (crohn's disease) stelara
STELARA® (ustekinumab) is indicated for the treatment of patients 6 years or older with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. STELARA® (ustekinumab) is indicated for the treatment of adult patients with moderately to severely active Crohn's disease.
Stelara® is a brand of ustekinumab that treats plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis. This medication treats symptoms of these conditions and it isn't a cure. A healthcare provider usually gives you this injection in a hospital or clinic setting.
Official answer. Yes, Stelara (ustekinumab) is a biologic. A biologic, also known as a biopharmaceutical, is a class of drugs made from naturally occurring molecules, such as proteins, genes, antibodies, sugars, tissues, or cells. This biologic drug blocks proteins that lead to inflammation.
Ustekinumab is a drug that reduces the signs and symptoms of active psoriatic arthritis, such as psoriasis and joint swelling. It is also approved for the treatment of plaque psoriasis and moderate to severe, active Crohn's disease. Ustekinumab is commonly known as Stelara®.
The cost for Stelara subcutaneous solution (45 mg/0.5 mL) is around $13,971 for a supply of 0.5 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans.
Ustekinumab (Stelara) is a biologic medication used to lower inflammation and help adult patients and patients six years or older with moderate to severe plaque psoriasis, adult patients with psoriatic arthritis, and adult patients with moderate to severe Crohn's Disease and Ulcerative Colitis.
Immune system suppressors
- Azathioprine (Azasan, Imuran) and mercaptopurine (Purinethol, Purixan). These are the most widely used immunosuppressants for treatment of inflammatory bowel disease.
- Methotrexate (Trexall). This drug is sometimes used for people with Crohn's disease who don't respond well to other medications.
Stelara drug substance is manufactured at Centocor Biologics, LLC 4777 LeBourget Drive St. Louis, MO 63134 USA.
The cost for Stelara subcutaneous solution (45 mg/0.5 mL) is around $13,971 for a supply of 0.5 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans.
Ustekinumab (Stelara) is a biologic medication used to lower inflammation and help adult patients and patients six years or older with moderate to severe plaque psoriasis, adult patients with psoriatic arthritis, and adult patients with moderate to severe Crohn's Disease and Ulcerative Colitis.
Ustekinumab, sold under the brand name Stelara, is a monoclonal antibody medication developed by Janssen Pharmaceuticals, for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and psoriatic arthritis, targeting both IL-12 and IL-23.
The cost for Stelara subcutaneous solution (45 mg/0.5 mL) is around $13,971 for a supply of 0.5 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans.
Stelara (ustekinumab) demonstrated strong efficacy and safety throughout 4 years of treatment in adult patients with moderately to severely active ulcerative colitis (UC), the Janssen Pharmaceutical Companies of Johnson & Johnson said at the United European Gastroenterology (UEG) Week 2022 congress 1 in Vienna, Austria ...
STELARA® is a prescription medicine that affects your immune system. It can increase your chance of having serious side effects including serious infections, cancer, serious allergic reactions, lung inflammation, and a rare condition called posterior reversible encephalopathy syndrome.
The cost for Stelara subcutaneous solution (45 mg/0.5 mL) is around $13,971 for a supply of 0.5 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans.
May 19, 2023, at 9:43 a.m. FRIDAY, May 19, 2023 (HealthDay News) -- Patients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).
